CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

FromCRISPR Cuts

Start listening View podcast show

CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

FromCRISPR Cuts

ratings:

Length:

18 minutes

Released:

Jan 12, 2021

Format:

Podcast episode

Description

In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021.

Released:

Jan 12, 2021

Format:

Podcast episode

Titles in the series (32)

Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.

Skip carousel

CRISPR for Curious Minds by CRISPR Cuts
41 min listen
Alex Philippidis Reviews Trends in Biopharma & Biotech Market: Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise... by CRISPR Cuts
28 min listen
Knockout Cell Pools Are Simplifying CRISPR Experiments: Dr. Ania Wronski, Product Manager for the Engineered Cells portfolio at Synthego, discusses how their new engineered cells products are enabling CRISPR access to researchers worldwide. Learn about the different ways in which researchers use knockout cell... by CRISPR Cuts
21 min listen
Reed Kelso Strives to Enable CRISPR Access For All Scientists: Reed Kelso, Head of Cell Engineering Research and Applications at Synthego, is a bio-wizard. In this episode, Kevin & Minu catch up with Reed about his role at Synthego and the day-to-day operations at the fast paced start-up. Reed talks about the revolu... by CRISPR Cuts
16 min listen
CRISPR in Gene Drives: Experts Opine: Gene drives have frequently been in the news in the past few years. In this episode, we discuss what exactly gene drives are, their applications, and how scientists are ensuring that they are used responsibly. Tune in to hear what researchers Anna Buchma... by CRISPR Cuts
11 min listen
Avery Posey Discusses CAR T Cell Cancer Therapies: Dr. Avery Posey is leading the charge on CAR T cell therapy research to bring this technology to cancer patients as soon as possible. Learn how CAR T works, what stage it’s in now, and how it will help revolutionize the treatment of cancer. by CRISPR Cuts
25 min listen
CRISPR in Fungi: An Interview with Rebecca Shapiro: Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interaction... by CRISPR Cuts
18 min listen
CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans: In this episode, Paul Dabrowski, CEO of Synthego, and Robert Deans, CSO of Synthego, discuss the CRISPR silver linings of 2020 and predict the directions and milestones for gene editing in 2021. by CRISPR Cuts
18 min listen
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes: Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. by CRISPR Cuts
13 min listen
Improving Targeted Delivery to Enhance Personalized Medicine: Andre Watson, CEO of Ligandal, talks about how his company is improving the payload delivery of gene therapy, making it more accurate and efficient, to make new gene therapy a reality for the public. by CRISPR Cuts
28 min listen
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller: Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this ... by CRISPR Cuts
10 min listen
CRISPR Office Hours with Hamid Ghanadaan: The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scie... by CRISPR Cuts
36 min listen
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature: What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film. by CRISPR Cuts
38 min listen
Kiana Aran Chats About her Nature Award and New Non-Profit: In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and awa... by CRISPR Cuts
41 min listen
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients: After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first t... by CRISPR Cuts
43 min listen
Michael Friend Advocates For Diversity in CRISPR: In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists. by CRISPR Cuts
19 min listen
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR: In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transformin... by CRISPR Cuts
31 min listen
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial: Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Ji... by CRISPR Cuts
40 min listen
Joe Miano Talks About Prime Editing in Mice: Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at ... by CRISPR Cuts
20 min listen
Kevin Davies Chats About His Latest Book "Editing Humanity": Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the N... by CRISPR Cuts
32 min listen
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling: The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at ... by CRISPR Cuts
37 min listen
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials: TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. by CRISPR Cuts
24 min listen
Ayal Hendel Talks About CRISPR in Bubble Boy Disease: Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the re... by CRISPR Cuts
36 min listen
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics: In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. by CRISPR Cuts
35 min listen
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells: In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells... by CRISPR Cuts
33 min listen
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top: We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. Tune in to this e... by CRISPR Cuts
63 min listen
Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology: Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, ONKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode they discussed what they do at oNKo-innate, their career ... by CRISPR Cuts
26 min listen
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases by CRISPR Cuts
20 min listen
Dina Simkin Breaks Down Epilepsy Cell Modeling: Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked... by CRISPR Cuts
27 min listen
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy: Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up. by CRISPR Cuts
29 min listen

More Episodes from CRISPR Cuts

Skip carousel

Imran House and Junyun Lai Discuss CRISPR Screening in Immuno-Oncology: Imran House, Ph.D. and Junyun Lai Ph.D. are Senior Scientists at the biotech start-up, ONKo-Innate in Melbourne, Australia that focuses on developing immuno-oncology therapies. In this episode they discussed what they do at oNKo-innate, their career ... by CRISPR Cuts
26 min listen
Mark DeWitt and Don Kohn Discuss Their ex vivo CRISPR-based Therapy to Cure Sickle Cell Anemia: Dr. Mark DeWitt Ph.D., Associate Director at Mammoth Biosciences, and Dr. Don Kohn M.D., distinguished professor and Director of the UCLA Human Gene and Cell Therapy Program and CIRM grantee sat down with us to discuss their latest clinical trials to... by CRISPR Cuts
33 min listen
Dina Simkin Breaks Down Epilepsy Cell Modeling: Dina Simkin, Professor of Neurology at Northwestern University, joins us in this episode of CRISPR Cuts. Dr. Simkin talks about her path to becoming a researcher, art, and the importance of patient and isogenic iPSC models to study genetically linked... by CRISPR Cuts
27 min listen
Sunil Sharma and Raffaella Soldi Talk CRISPR For Unbiased Drug Screening for Rare Pediatric Cancers: Dr. Sunil Sharma and Dr. Raffaella Soldi of the Translational Genomics Research Institute chat about using CRISPR arrayed screens to identify novel drug targets for Ewing's Sarcoma, outlooks for the future of cancer therapies, and the Arizona heat. by CRISPR Cuts
25 min listen
Stephanie Cherqui Discusses Clinical Development of CRISPR Therapies for Rare Diseases by CRISPR Cuts
20 min listen
Christian Groendahl On Pioneering a CRISPR-based Microbial Gene Therapy: Tune in to hear Christian Groendahl, CEO of SNIPR Biome, talk about CRISPR editing in prokaryotes, their novel E. coli-targeting CRISPR therapy trials, and his experiences and vision leading a start up. by CRISPR Cuts
29 min listen
Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics: In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility. by CRISPR Cuts
35 min listen
Ayal Hendel Talks About CRISPR in Bubble Boy Disease: Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the re... by CRISPR Cuts
36 min listen
Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial: Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising results from the early phases. Tune in to learn about Ji... by CRISPR Cuts
40 min listen
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials: TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases. by CRISPR Cuts
24 min listen
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients: After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized therapies. Hear the patient perspective for the first t... by CRISPR Cuts
43 min listen
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells: In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were used to enhance CRISPR-Cas13 knockdown in human cells... by CRISPR Cuts
33 min listen
Kiana Aran Chats About her Nature Award and New Non-Profit: In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. Aran talks about her experience being a nominee and awa... by CRISPR Cuts
41 min listen
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top: We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.— about their professional journeys. Tune in to this e... by CRISPR Cuts
63 min listen
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR: In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancers. He also covers how CRISPR technology is transformin... by CRISPR Cuts
31 min listen
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling: The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. Michael E. Ward and Dr. Mark R. Cookson, scientists at ... by CRISPR Cuts
37 min listen
Joe Miano Talks About Prime Editing in Mice: Prime editing is a new genome engineering tool that emerged just a couple of years back. Right from the get-go, this technology made waves as a potential alternative to CRISPR. Now, the first comparative study in mice is out. Dr. Joe Miano, Professor at ... by CRISPR Cuts
20 min listen
Kevin Davies Chats About His Latest Book "Editing Humanity": Kevin Davies, the executive editor of The CRISPR Journal, has closely watched the genetics space evolve over the last decades. His expertise and experience were the perfect foundation for his latest book "Editing Humanity: The CRISPR Revolution and the N... by CRISPR Cuts
32 min listen
Michael Friend Advocates For Diversity in CRISPR: In this episode, Michael Friend, CEO of Minority Coalition for Precision Medicine, discusses the lack of diversity in genome editing field and covers potential solutions for ensuring an inclusive future, particularly for black scientists. by CRISPR Cuts
19 min listen
CRISPR Office Hours with Hamid Ghanadaan: The COVID-19 pandemic is a unique situation for lab scientists, many of whose work has come to a standstill. Hamid Ghanadaan, CEO of Linus, discusses the impact of COVID-19 on science and the next steps for scientists, based on their survey of >1000 scie... by CRISPR Cuts
36 min listen
Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature: What is the process to make a science film? In this episode, Sarah Goodwin and Elliot Kirschner, producers of Human Nature, a documentary on CRISPR, offer glimpses into making of the film. by CRISPR Cuts
38 min listen
Leading St. Jude's Genome Engineering Capabilities: A Chat with Shondra Miller: Shondra Miller shares her experience of starting a shared genome engineering resource at the St. Jude Children's Research Hospital. Learn more about her research projects and her views on the past, present, and future of the genome editing field in this ... by CRISPR Cuts
10 min listen
The Potential of CRISPR Editing in Stem Cells: An Interview with Bill Skarnes: Dr. Bill Skarnes, Professor at The Jackson Laboratory, chats about how CRISPR edited stem cells are becoming a gold standard to study gene function and disease modeling. by CRISPR Cuts
13 min listen
CRISPR in Fungi: An Interview with Rebecca Shapiro: Rebecca Shapiro, Assistant Professor at the University of Guelph, talks about CRISPR genome editing in fungal pathogens to understand their disease-causing mechanism. Her lab also works on gene drives in fungi for studying large scale genetic interaction... by CRISPR Cuts
18 min listen

Related podcast episodes

Skip carousel

The Jim Day Podcast- Writers Roundtable Reds Season Wrap by The Jim Day Podcast
60 min listen
The Evolving World of RNA Editing with Dr. David Nelles: Up until recently, DNA has dominated the field of technological development. However, RNA is slowly but surely finding its place on the stage. Although it is more fragile, and therefore more difficult to handle, by FYI - For Your Innovation
43 min listen
The DSR Gang Looks Ahead to 2024 by Deep State Radio
48 min listen
Episode 9: Neurodiversity with Richard Everard: In this month’s episode, in recognition of World … by Cisco Podcast Network
58 min listen
Products. Process. Purpose. The Start of 2022 Is Here and We Share Our Vision for hyperCLEAN!!! by Pints & Polishing Auto Detailing Podcast
45 min listen
Tech-Themed ETFs, Dow Shakeup & IPO Market: CNBC's Bob Pisani spoke with Todd Rosenbluth, senior director of ETF and mutual fund research at CFRA Research, Jay Jacobs, Head of Research and Strategy at Global X Funds, and Mona Naqvi, Head of ESG Index Strategy at S&P Dow Jones Indices. Today they discussed the top thematic tech and software plays, what the world's biggest IPO could mean for ETFs, and why ESG has been so strong and the possible challenges ahead. In the markets 102 segment, Bob discussed the Dow's big shakeup and what it could mean for your money. by ETF Edge
25 min listen
CI to Eye | Words of Inspiration To Power 2024: CI to Eye is back with a healthy dose of inspiration to help you re-center at the top of the new year. In 2023, we spoke with remarkable thought leaders both within and beyond the realm of the arts. Guests ranged from executive directors and arts... by CI to Eye
17 min listen
NCDA Updates: 2022 Conference Overview with Dr. Sharon Givens by Career Practitioner Conversations with NCDA
18 min listen
Gold ETFs, Online Retail & ETN Delisting Dangers: CNBC’s Bob Pisani speaks with Dave Nadig, chief investment officer and director of research at ETF Trends and ETF Database, and Chris Hempstead, director of institutional business development at IndexIQ. They discussed exchange-traded note delistings and the risks they pose to investors, gold’s winning streak this year, online retail, and some top headlines in the ETF space. In the markets 102 segment Bob discusses the work from home ETF. by ETF Edge
22 min listen
The Nats Insider Podcast - Episode 15: The Nats Insider Podcast - Episode 15 by Nats Insider
32 min listen
EP 64: Arizona Elk Strategy - Details and Drought: Arizona - Elk Hunter's Promised Land by Elk Talk
87 min listen
Episode 4: International Women’s Day with Wendy Mars and Shane Heraty: In this month’s episode we’re celebrating Interna… by Cisco Podcast Network
61 min listen
Ep. 45 | Rangefinders with the Glassing Guru by Big Hunt Guys
82 min listen
BONUS DORK: This Year in #DORK - 2020 by #DORK
76 min listen
#13: Predictions for the Business of Golf in 2022: Roberto and Dan kick off 2022 with predictions for 2022. We discuss non-green grass golf, betting in golf, golf media, the future of startup golf leagues (PGL, SGL), direct to consumer brands, and gender equity in golf. Stay tuned throughout the year by Course Record Show
39 min listen
2.2 Primer for RheumMadness 2022 by RheumMadness Podcast
31 min listen
Emerging Trends in Parks and Recreation — January Bonus Episode: A replay of the "Emerging Trends in Parks and Recreation" Coffee Talk from the 2020 NRPA Annual Conference: A Virtual Experience (NRPA Virtual) by Open Space Radio: Parks and Recreation Trends
32 min listen
Looking Ahead to 2022 by Head Start
50 min listen
MLB Draft Podcast: More Thoughts On 2020 & Looking Ahead To 2021 by Baseball America
46 min listen
Turning the Page With Rachel Drori, Founder & CEO of Daily Harvest by Hurdle
23 min listen
Bonus - Colorado Elk & Deer 2021: Hunt Colorado in 2021 by Hunt Talk Radio
16 min listen
E17: The Edge of Normal by Facts vs Feelings with Ryan Detrick & Sonu Varghese
31 min listen
Ep16: Green Bonds and Sustainable Investing: https://www.nortonrosefulbright.com/en-us/people/122497 and https://www.nortonrosefulbright.com/en-us/people/123139 join https://www.nortonrosefulbright.com/en-US/people/1006920 and https://www.nortonrosefulbright.com/en-us/people/1015979 for a... by Earth, Wind and Solar
29 min listen
A College Perspective of the Ravens 2020 draft with help from Locked On Big Ten and Locked On Ducks: Today we get a bit of a college perspective on the Ravens 2020 draft with a few experts. Ben Stevens of Locked On Big Ten and Jordan Long of Locked On Ducks join the show to talk about the prospects that come from their respective schools and conferences, including J.K. Dobbins, Malik Harrison, Jacob Breeland, and more! Learn more about your ad choices. Visit podcastchoices.com/adchoices by Locked On Ravens - Daily Podcast On The Baltimore Ravens
29 min listen
The Top HR Trends that are Set to Disrupt the Workplace in 2023 (an interview with Diane Gherson, Dave Ulrich and David Green) by Digital HR Leaders with David Green
43 min listen
01/03/2017 - Locked On NFL Draft - BPA vs. Team Need and Draft Philosophies: Co-hosts Joe Marino and Kyle Crabbs are joined by Roger Dixon Jr. to discuss philosophies of Draft board production and how to target prospects via @LockedOnNetwork. Powered by @Draftbreakdown. by Locked On NFL Draft - Daily Podcast On The NFL Draft, College Football & The NFL
30 min listen
Inside Vanguard HQ: Sizing Up ETFs, Rates & Big Tech in the Year Ahead 10/27/23: CNBC’s Bob Pisani sat down on the trading floor at Vanguard HQ, where he caught up with Vanguard CIO Greg Davis and Janel Jackson, Global Head of ETF Capital Markets and Broker and Index Relations at Vanguard. Our panel of experts broke down top ETF gave us a glimpse of where the flows could be headed next. They also weighed in on the mega-cap tech trade and handicapped the Fed’s next policy moves, outlook for the global economy, equities and interest rates in 2024. In the “Markets 102” portion, Bob continued the conversation with Vanguard’s Janel Jackson. by ETF Edge
29 min listen
Basement of Hell (with Eason Yang) by Did I Do That?: Making Graphic Design & Mistakes
74 min listen
What are you optimizing for?: featuring Saron Yitbarek by Founders Talk: Startups, CEOs, Leadership
74 min listen
2024: A look ahead by Raw Pet Medics
39 min listen

Discover this podcast and so much more

CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

CRISPR Forecast 2021 with Paul Dabrowski and Robert Deans

Description

Titles in the series (32)

More Episodes from CRISPR Cuts

Related podcast episodes